IBDEI1QJ ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30694,1,3,0)
 ;;=3^Atyp squam cell not excl hi grd intrepith lesn cyto smr crvx
 ;;^UTILITY(U,$J,358.3,30694,1,4,0)
 ;;=4^R87.611
 ;;^UTILITY(U,$J,358.3,30694,2)
 ;;=^5019669
 ;;^UTILITY(U,$J,358.3,30695,0)
 ;;=R87.612^^178^1924^65
 ;;^UTILITY(U,$J,358.3,30695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30695,1,3,0)
 ;;=3^Low grade intrepith lesion cyto smr crvx (LGSIL)
 ;;^UTILITY(U,$J,358.3,30695,1,4,0)
 ;;=4^R87.612
 ;;^UTILITY(U,$J,358.3,30695,2)
 ;;=^5019670
 ;;^UTILITY(U,$J,358.3,30696,0)
 ;;=R87.613^^178^1924^56
 ;;^UTILITY(U,$J,358.3,30696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30696,1,3,0)
 ;;=3^High grade intrepith lesion cyto smr crvx (HGSIL)
 ;;^UTILITY(U,$J,358.3,30696,1,4,0)
 ;;=4^R87.613
 ;;^UTILITY(U,$J,358.3,30696,2)
 ;;=^5019671
 ;;^UTILITY(U,$J,358.3,30697,0)
 ;;=R87.810^^178^1924^27
 ;;^UTILITY(U,$J,358.3,30697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30697,1,3,0)
 ;;=3^Cervical high risk HPV DNA test positive
 ;;^UTILITY(U,$J,358.3,30697,1,4,0)
 ;;=4^R87.810
 ;;^UTILITY(U,$J,358.3,30697,2)
 ;;=^331573
 ;;^UTILITY(U,$J,358.3,30698,0)
 ;;=R87.614^^178^1924^36
 ;;^UTILITY(U,$J,358.3,30698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30698,1,3,0)
 ;;=3^Cytologic evidence of malignancy on smear of cervix
 ;;^UTILITY(U,$J,358.3,30698,1,4,0)
 ;;=4^R87.614
 ;;^UTILITY(U,$J,358.3,30698,2)
 ;;=^5019672
 ;;^UTILITY(U,$J,358.3,30699,0)
 ;;=Z85.3^^178^1924^77
 ;;^UTILITY(U,$J,358.3,30699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30699,1,3,0)
 ;;=3^Personal history of malignant neoplasm of breast
 ;;^UTILITY(U,$J,358.3,30699,1,4,0)
 ;;=4^Z85.3
 ;;^UTILITY(U,$J,358.3,30699,2)
 ;;=^5063416
 ;;^UTILITY(U,$J,358.3,30700,0)
 ;;=Z85.43^^178^1924^78
 ;;^UTILITY(U,$J,358.3,30700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30700,1,3,0)
 ;;=3^Personal history of malignant neoplasm of ovary
 ;;^UTILITY(U,$J,358.3,30700,1,4,0)
 ;;=4^Z85.43
 ;;^UTILITY(U,$J,358.3,30700,2)
 ;;=^5063420
 ;;^UTILITY(U,$J,358.3,30701,0)
 ;;=Z80.41^^178^1924^51
 ;;^UTILITY(U,$J,358.3,30701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30701,1,3,0)
 ;;=3^Family history of malignant neoplasm of ovary
 ;;^UTILITY(U,$J,358.3,30701,1,4,0)
 ;;=4^Z80.41
 ;;^UTILITY(U,$J,358.3,30701,2)
 ;;=^5063348
 ;;^UTILITY(U,$J,358.3,30702,0)
 ;;=Z30.011^^178^1924^60
 ;;^UTILITY(U,$J,358.3,30702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30702,1,3,0)
 ;;=3^Initial Prescription of Contraceptive Pills
 ;;^UTILITY(U,$J,358.3,30702,1,4,0)
 ;;=4^Z30.011
 ;;^UTILITY(U,$J,358.3,30702,2)
 ;;=^5062810
 ;;^UTILITY(U,$J,358.3,30703,0)
 ;;=Z30.018^^178^1924^61
 ;;^UTILITY(U,$J,358.3,30703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30703,1,3,0)
 ;;=3^Initial Prescription of Contraceptives NEC
 ;;^UTILITY(U,$J,358.3,30703,1,4,0)
 ;;=4^Z30.018
 ;;^UTILITY(U,$J,358.3,30703,2)
 ;;=^5062814
 ;;^UTILITY(U,$J,358.3,30704,0)
 ;;=Z30.012^^178^1924^43
 ;;^UTILITY(U,$J,358.3,30704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30704,1,3,0)
 ;;=3^Emergency Contraception Prescription
 ;;^UTILITY(U,$J,358.3,30704,1,4,0)
 ;;=4^Z30.012
 ;;^UTILITY(U,$J,358.3,30704,2)
 ;;=^5062811
 ;;^UTILITY(U,$J,358.3,30705,0)
 ;;=Z30.02^^178^1924^32
 ;;^UTILITY(U,$J,358.3,30705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30705,1,3,0)
 ;;=3^Cnsl and instruction in natrl family planning to avoid preg
 ;;^UTILITY(U,$J,358.3,30705,1,4,0)
 ;;=4^Z30.02
 ;;^UTILITY(U,$J,358.3,30705,2)
 ;;=^5062816
 ;;^UTILITY(U,$J,358.3,30706,0)
 ;;=Z30.430^^178^1924^62
 ;;^UTILITY(U,$J,358.3,30706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30706,1,3,0)
 ;;=3^Insert Intrauterine Contraceptive Device
 ;;
 ;;$END ROU IBDEI1QJ
